Department of Dietetics, National University Hospital, Singapore.
Department of Pediatrics, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia; Pediatrics and Child Health Research Group, University Malaya, Kuala Lumpur, Malaysia.
Pediatr Neonatol. 2018 Oct;59(5):494-500. doi: 10.1016/j.pedneo.2017.12.007. Epub 2017 Dec 26.
The use of complementary and alternative medicine (CAM) has been associated with adverse effects and self-imposed dietary restrictions. The prevalence of its use in Asian children with inflammatory bowel disease (IBD) is unknown. We aimed to determine the prevalence, types, and factors associated with the use of CAM among children with IBD from Singapore and Malaysia, and to ascertain if dietary restriction was prevalent in patients who used CAM.
A cross-sectional study was conducted in which parents of children with IBD attending two tertiary pediatric IBD referral centres in Singapore and Malaysia were interviewed. Data about demographics, conventional treatment, complementary therapies and dietary patterns were collected in a questionnaire.
Of 64 children with IBD interviewed, 83% (n = 53) reported the use of CAM (Singapore [90%] vs. Malaysia [76%]; p = 0.152). The median number of CAM agents used was two (range 1-10). The three most common types of CAM used were probiotics (64%), vitamin and mineral supplements (55%), and food-based therapies (36%). Among individual CAM categories, the use of food-based therapies was correlated significantly with nationality (r = 0.497, p < 0.001), history of weight loss due to IBD (r = 0.340, p = 0.013) and avoidance of certain foods to prevent a relapse (r = 0.289, p = 0.036). Parents who rated their child's disease activity as more severe were less likely to use CAM (r = -0.257, p = 0.041). Fifty-nine percent of CAM users reported physician awareness of their CAM use. The overall self-perceived efficacy of CAM in improving IBD symptoms was 34%. Of the dietary patterns explored, only intake of dairy products was associated with CAM use (r = 0.306, p = 0.019).
Use of CAM is prevalent in children with IBD in Malaysia and Singapore. Further studies to elucidate reasons influencing CAM use, dietary patterns and efficacy of commonly used CAM would be required.
补充和替代医学(CAM)的使用与不良反应和自我实施的饮食限制有关。亚洲炎症性肠病(IBD)患儿使用 CAM 的流行情况尚不清楚。我们旨在确定新加坡和马来西亚的 IBD 患儿使用 CAM 的流行率、类型和相关因素,并确定使用 CAM 的患者是否存在饮食限制。
进行了一项横断面研究,对在新加坡和马来西亚的两家三级儿科 IBD 转诊中心就诊的 IBD 患儿的父母进行了访谈。在问卷中收集了有关人口统计学、常规治疗、补充疗法和饮食模式的数据。
在接受采访的 64 名 IBD 患儿中,83%(n=53)报告使用了 CAM(新加坡[90%] vs. 马来西亚[76%];p=0.152)。使用的 CAM 药物中位数为两种(范围 1-10)。使用最多的三种 CAM 类型是益生菌(64%)、维生素和矿物质补充剂(55%)和基于食物的疗法(36%)。在个别 CAM 类别中,基于食物的疗法的使用与国籍显著相关(r=0.497,p<0.001)、因 IBD 导致的体重减轻史(r=0.340,p=0.013)和避免某些食物以防止复发(r=0.289,p=0.036)。父母认为孩子的疾病活动更严重时,他们不太可能使用 CAM(r=-0.257,p=0.041)。59%的 CAM 用户报告医生了解他们的 CAM 使用情况。CAM 改善 IBD 症状的总体自我感知疗效为 34%。在所探讨的饮食模式中,只有奶制品的摄入量与 CAM 的使用相关(r=0.306,p=0.019)。
CAM 在新加坡和马来西亚的 IBD 患儿中广泛使用。需要进一步研究以阐明影响 CAM 使用、饮食模式和常用 CAM 疗效的原因。